# Pulsed Field Ablation vs Cryoablation In Paroxysmal Atrial Fibrillation

Study · id `cardio:ct-nct05940597` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05940597](<https://clinicaltrials.gov/study/NCT05940597>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT05940597

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 354 participants.

## Technical summary

Registry record NCT05940597. Randomized; no masking; primary purpose treatment. Start 2023-09-25 (actual); primary completion 2026-03-23 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 354 participants (enrolled count; ClinicalTrials.gov record NCT05940597, source copy `cardio:ctgov-nct05940597-2026-10-26`, retrieved 2026-10-31)
- Started: 2023-09-25 (actual) (ClinicalTrials.gov record NCT05940597, source copy `cardio:ctgov-nct05940597-2026-10-26`, retrieved 2026-10-31)
- Primary completion: 2026-03-23 (actual) (ClinicalTrials.gov record NCT05940597, source copy `cardio:ctgov-nct05940597-2026-10-26`, retrieved 2026-10-31)
- Completion: 2026-03-23 (actual) (ClinicalTrials.gov record NCT05940597, source copy `cardio:ctgov-nct05940597-2026-10-26`, retrieved 2026-10-31)
- Countries: France (ClinicalTrials.gov record NCT05940597, source copy `cardio:ctgov-nct05940597-2026-10-26`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05940597-2026-10-26`, retrieved 2026-10-31)

## The registry's words

- Brief title: Pulsed Field Ablation vs Cryoablation In Paroxysmal Atrial Fibrillation
- Acronym: FACIL AF
- Condition: Atrial Fibrillation Paroxysmal
- Intervention (Device): Pulse field ablation
- Intervention (Device): Cryoballoon pulmonary vein isolation
- Lead sponsor: University Hospital, Grenoble
- Lead sponsor class: OTHER
- Collaborator: Boston Scientific Corporation
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)
- Registry lists this organization as the lead sponsor: University Hospital, Grenoble (`cardio:org-university-hospital-grenoble`)
- Registry lists this organization as a collaborator: Boston Scientific (`cardio:boston-scientific`)

## Provenance

Content hash: 164ce30c2314f82e6f1daac858d4aa8c1c1fdfd29245d9f7e46df63e300a9c08
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
